Ratings by Benchmark (Robert Wasserman)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2026 Halozyme Therapeutics HALO Maintain Buy
(Buy)
 
 
  Details
6/2/2026 Emergent BioSolutions EBS Maintain Buy
(Buy)
 
 
  Details
5/22/2026 XOMA, Ltd. XOMA Downgrade Hold
(Buy)
41.82
(41.95)
0.31% Details
5/20/2026 Intensity Therapeutics, Inc. INTS Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
5/19/2026 Kamada Ltd. KMDA Maintain Buy
(Buy)
 
 
  Details
3/24/2026 Codexis, Inc. CDXS Maintain Hold
(Hold)
 
 
  Details
3/18/2026 Nephros NEPH Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
3/17/2026 MindWalk Holdings HYFT Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
3/12/2026 Kamada Ltd. KMDA Maintain Buy
(Buy)
 
 
  Details
3/6/2026 OmniAb, Inc. OABI Maintain Buy
(Buy)
 
 
  Details
2/20/2026 Integer Holding ITGR Upgrade Buy
(Hold)
83.00
(89.54)
7.88% Details
2/19/2026 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
2/5/2026 Proto Labs PRLB Maintain Buy
(Buy)
 
 
  Details
2/3/2026 Halozyme Therapeutics HALO Maintain Buy
(Buy)
 
 
  Details
2/3/2026 Bio-Techne Corp. TECH Maintain Buy
(Buy)
 
 
  Details
1/8/2026 Kamada Ltd. KMDA Maintain Buy
(Buy)
 
 
  Details
12/12/2025 XOMA, Ltd. XOMA Maintain Buy
(Buy)
 
 
  Details
12/10/2025 Ligand Pharma LGND Maintain Buy
(Buy)
 
 
  Details
11/7/2025 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
11/6/2025 OmniAb, Inc. OABI Maintain Buy
(N/A)
 
 
  Details
11/3/2025 Proto Labs PRLB Maintain Buy
(N/A)
 
 
  Details
10/24/2025 Integer Holding ITGR Downgrade Hold
(Buy)
73.89
(89.54)
21.18% Details
9/24/2025 Halozyme Therapeutics HALO Maintain Buy
(Buy)
 
 
  Details
9/9/2025 XOMA, Ltd. XOMA Maintain Buy
(Buy)
 
 
  Details
9/2/2025 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
8/20/2025 Intensity Therapeutics, Inc. INTS Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
8/19/2025 Codexis, Inc. CDXS Maintain Hold
(Hold)
 
 
  Details
8/14/2025 Kamada Ltd. KMDA Maintain Buy
(Buy)
 
 
  Details
8/13/2025 AbCellera Biologics ABCL Maintain Hold
(Hold)
 
 
  Details
8/12/2025 Nephros NEPH Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
8/8/2025 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
7/28/2025 Integer Holding ITGR Maintain Buy
(Buy)
 
 
  Details
6/5/2025 Bio-Techne Corp. TECH Maintain Buy
(Buy)
 
 
  Details
5/22/2025 Anebulo Pharmaceuticals ANEB Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
5/21/2025 Intensity Therapeutics, Inc. INTS Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
5/15/2025 Kamada Ltd. KMDA Maintain Buy
(Buy)
 
 
  Details
5/8/2025 Bio-Techne Corp. TECH Maintain Buy
(N/A)
 
 
  Details
5/7/2025 Halozyme Therapeutics HALO Maintain Hold
(Hold)
 
 
  Details
5/5/2025 Proto Labs PRLB Maintain Buy
(Buy)
 
 
  Details
4/25/2025 Integer Holding ITGR Maintain Buy
(N/A)
 
 
  Details
4/17/2025 XOMA, Ltd. XOMA New Coverage Buy
(N/A)
20.53
(41.82)
103.7% Details
4/1/2025 Immunoprecise Antibodies Ltd. IPA Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
3/21/2025 Kamada Ltd. KMDA New Coverage Buy
(N/A)
6.65
(7.13)
7.22% Details
3/20/2025 OmniAb, Inc. OABI Maintain Buy
(N/A)
 
 
  Details
3/19/2025 Intensity Therapeutics, Inc. INTS Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
3/4/2025 BioLife Solutions BLFS Maintain Buy
(Buy)
 
 
  Details
3/3/2025 AbCellera Biologics ABCL Maintain Hold
(Hold)
 
 
  Details
2/24/2025 Repligen RGEN Maintain Hold
(Hold)
 
 
  Details
2/21/2025 Integer Holding ITGR Maintain Buy
(N/A)
 
 
  Details
2/11/2025 Proto Labs PRLB Maintain Buy
(Buy)
 
 
  Details
1/23/2025 Immunoprecise Antibodies Ltd. IPA Maintain Buy
(Buy)
 
 
  Details
12/23/2024 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
12/19/2024 BioLife Solutions BLFS Maintain Buy
(N/A)
 
 
  Details
11/8/2024 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
11/7/2024 Emergent BioSolutions EBS Maintain Buy
(N/A)
 
 
  Details
10/21/2024 Integer Holding ITGR Maintain Buy
(N/A)
 
 
  Details
10/2/2024 Integer Holding ITGR Maintain Buy
(Buy)
 
 
  Details
10/1/2024 Anebulo Pharmaceuticals ANEB Maintain Speculative Buy
(Speculative Buy)
 
 
  Details
8/22/2024 Nephros NEPH Maintain Speculative Buy
(N/A)
 
 
  Details
8/20/2024 AbCellera Biologics ABCL Downgrade Hold
(Buy)
2.71
(5.63)
107.75% Details
8/19/2024 Codexis, Inc. CDXS Downgrade Hold
(Buy)
2.91
(2.39)
-17.87% Details
8/14/2024 Immunoprecise Antibodies Ltd. IPA Maintain Speculative Buy
(N/A)
 
 
  Details
6/25/2024 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
6/20/2024 Emergent BioSolutions EBS Maintain Buy
(N/A)
 
 
  Details
5/13/2024 BioLife Solutions BLFS Upgrade Buy
(Neutral)
19.54
(24.79)
26.87% Details
3/28/2024 Integer Holding ITGR Maintain Buy
(N/A)
 
 
  Details
3/8/2024 Nephros NEPH Upgrade Speculative Buy
(Hold)
3.02
(3.30)
9.27% Details
3/7/2024 Emergent BioSolutions EBS Upgrade Buy
(Hold)
3.26
(8.01)
145.71% Details
2/29/2024 Codexis, Inc. CDXS Upgrade Buy
(Hold)
3.72
(2.39)
-35.75% Details
2/22/2024 AbCellera Biologics ABCL Upgrade Buy
(Hold)
4.81
(5.63)
17.05% Details
12/4/2023 Repligen RGEN Downgrade Hold
(Buy)
164.94
(126.37)
-23.38% Details
11/7/2023 Codexis, Inc. CDXS Downgrade Hold
(Buy)
1.75
(2.39)
36.57% Details
11/6/2023 AbCellera Biologics ABCL Downgrade Hold
(Buy)
4.70
(5.63)
19.79% Details
11/1/2023 Bio-Techne Corp. TECH Maintain Buy
(N/A)
 
 
  Details
8/31/2023 AbCellera Biologics ABCL Maintain Buy
(N/A)
 
 
  Details
8/29/2023 Emergent BioSolutions EBS Downgrade Hold
(Buy)
4.42
(8.01)
81.22% Details
8/25/2023 Molekule Group, Inc. MKUL Downgrade Hold
(Buy)
1.19
(0.05)
-95.8% Details
7/28/2023 Integer Holding ITGR Maintain Buy
(N/A)
 
 
  Details
7/18/2023 Intensity Therapeutics, Inc. INTS New Coverage Speculative Buy
(N/A)
5.89
(4.00)
-32.09% Details
5/10/2023 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
5/9/2023 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
5/3/2023 Repligen RGEN Maintain Buy
(N/A)
 
 
  Details
4/21/2023 OmniAb, Inc. OABI New Coverage Buy
(N/A)
3.59
(2.33)
-35.1% Details
4/10/2023 Emergent BioSolutions EBS Upgrade Buy
(Hold)
10.56
(8.01)
-24.15% Details
3/28/2023 Repligen RGEN New Coverage Buy
(N/A)
160.25
(164.94)
2.93% Details
3/21/2023 Immunoprecise Antibodies Ltd. IPA Downgrade Speculative Buy
(Buy)
3.08
(2.07)
-32.79% Details
3/16/2023 Champions Oncology CSBR Downgrade Hold
(Buy)
4.10
(6.23)
51.95% Details
2/14/2023 Anebulo Pharmaceuticals ANEB Maintain Speculative Buy
(N/A)
 
 
  Details
2/13/2023 Proto Labs PRLB Upgrade Buy
(Hold)
34.43
(79.81)
131.8% Details
12/8/2022 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
11/17/2022 AeroClean Thechnologies Inc. AERC Downgrade Speculative Buy
(Buy)
3.27
(3.40)
3.98% Details
11/10/2022 Emergent BioSolutions EBS Downgrade Hold
(Buy)
12.85
(8.01)
-37.67% Details
11/2/2022 Bio-Techne Corp. TECH Maintain Buy
(N/A)
 
 
  Details
10/27/2022 Thor Industries Inc. THO Downgrade Hold
(Buy)
79.27
(72.85)
-8.1% Details
10/24/2022 Danaher DHR Downgrade Hold
(Buy)
244.59
(178.97)
-26.83% Details
8/18/2022 AeroClean Thechnologies Inc. AERC Upgrade Speculative Buy
(Hold)
4.34
(3.40)
-21.66% Details
7/15/2022 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
6/14/2022 AeroClean Thechnologies Inc. AERC Downgrade Hold
(Buy)
17.25
(4.34)
-74.84% Details
6/7/2022 AeroClean Thechnologies Inc. AERC Maintain Speculative Buy
(N/A)
 
 
  Details
5/17/2022 Anebulo Pharmaceuticals ANEB Maintain Speculative Buy
(N/A)
 
 
  Details
5/9/2022 Nephros NEPH Downgrade Hold
(Speculative Buy)
2.21
(3.30)
49.32% Details
2/22/2022 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
2/1/2022 AeroClean Thechnologies Inc. AERC New Coverage Speculative Buy
(N/A)
4.94
(17.25)
249.19% Details
1/20/2022 Emergent BioSolutions EBS Upgrade Buy
(Neutral)
45.59
(8.01)
-82.43% Details
12/21/2021 AbCellera Biologics ABCL New Coverage Buy
(N/A)
14.60
(5.63)
-61.44% Details
11/8/2021 Emergent BioSolutions EBS Downgrade Hold
(Buy)
52.61
(8.01)
-84.77% Details
10/29/2021 Proto Labs PRLB Downgrade Hold
(Buy)
58.64
(34.43)
-41.29% Details
10/25/2021 Immunoprecise Antibodies Ltd. IPA New Coverage Buy
(N/A)
6.19
(2.07)
-66.56% Details
9/22/2021 Thermo Fisher Scientific TMO Maintain Hold
(N/A)
 
 
  Details
7/16/2021 Danaher DHR New Coverage Buy
(N/A)
280.95
(178.97)
-36.3% Details
7/16/2021 Thermo Fisher Scientific TMO New Coverage Buy
(N/A)
514.48
(469.35)
-8.77% Details
5/25/2021 Anebulo Pharmaceuticals ANEB New Coverage Buy
(N/A)
8.00
(0.36)
-95.5% Details
5/14/2021 BioLife Solutions BLFS Downgrade Neutral
(Buy)
29.53
(24.79)
-16.05% Details
4/13/2021 Bio-Techne Corp. TECH Maintain Buy
(N/A)
 
 
  Details
4/7/2021 Emergent BioSolutions EBS New Coverage Buy
(N/A)
79.25
(8.01)
-89.89% Details
3/23/2021 BioLife Solutions BLFS Upgrade Buy
(Hold)
38.57
(24.79)
-35.73% Details
1/21/2021 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
8/11/2020 BioLife Solutions BLFS Downgrade Hold
(Buy)
22.57
(24.79)
9.84% Details
7/15/2020 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
7/1/2020 Halozyme Therapeutics HALO New Coverage Buy
(N/A)
26.81
(69.62)
159.68% Details
5/14/2020 Bio-Techne Corp. TECH New Coverage Buy
(N/A)
261.83
(56.26)
-78.51% Details
5/14/2020 Proto Labs PRLB New Coverage Buy
(N/A)
96.62
(58.64)
-39.31% Details
5/14/2020 Integer Holding ITGR New Coverage Buy
(N/A)
70.64
(73.89)
4.6% Details
3/10/2020 Codexis, Inc. CDXS New Coverage Buy
(N/A)
11.43
(2.39)
-79.09% Details
2/19/2020 BioLife Solutions BLFS New Coverage
(N/A)
15.54
(24.79)
59.52% Details
2/6/2020 Ligand Pharma LGND New Coverage Buy
(N/A)
92.19
(279.44)
203.11% Details
11/18/2019 Champions Oncology CSBR New Coverage Speculative Buy
(N/A)
5.39
(6.23)
15.58% Details
10/24/2019 Nephros NEPH New Coverage Speculative Buy
(N/A)
9.61
(3.30)
-65.66% Details